TRU-SENTIMENT ยท DeltaNeutral
NKTR Trading Analysis - 11/06/2026 11:11 AM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
NKTR (Nektar Therapeutics) at $36.64. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,470 vs put $0. RSI 52.4.
- Symbol
- NKTR
- Price
- $36.64
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-11-06 11:11:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From NKTR_options_20261106 data:
Call Dollar Volume: 2470.00 (100.00%) Put Dollar Volume: 0.00 (0.00%) Total: 2470.00
Sentiment: Bullish (2 trades, 4 contracts, delta 40-60 filter). Pure directional call conviction with zero put activity. This diverges from bearish technicals (Option Spread advice: "Divergence detected between technical indicators and options sentiment"). Near-term expectations implied: modest bullish bet, but low sample (0.4% of 516 options analyzed).
Key Statistics: NKTR
Fundamental Snapshot
Valuation
| P/E (trailing) | 4.50 |
| EPS (trailing 12 mo) | $-2.87 |
| Market cap | $1.25B |
| Shares outstanding | 34.1M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 1.34 |
| 52-week low | $33.40 |
| 52-week high | $109.00 |
| Historical volatility | 90.8% |
Ownership & trading
| Institutional ownership | 45.4% |
| Average daily volume | 0.8M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
The following context items are based on general knowledge of Nektar Therapeutics (NKTR) and are separated from the data-driven analysis below:
- NKTR has historically been a clinical-stage biopharma name with pipeline readouts driving sharp volatility; recent years saw repositioning away from prior failed partnerships.
- Potential near-term catalyst: upcoming December options expiration may coincide with year-end pipeline or cash-runway commentary.
- Biotech sector sentiment has been mixed, with small-cap names facing liquidity pressure amid higher rates.
- No confirmed earnings date in provided data, but historical fiscal year end is 2025-12-01 per fundamentals.
- Headlines of dilution or deleveraging could relate to the steep SeptโOct 2026 drawdown seen in daily history data.
Fundamental Analysis
Based strictly on the embedded FUNDAMENTALS data for NKTR:
- Trailing P/E: 4.50 (note: trailing EPS is negative at -2.87, so P/E is non-meaningful / distorted).
- Trailing EPS: -2.87, indicating the company is not profitable on a trailing basis.
- Market Cap: 1,254,072,390.00; Shares Outstanding: 34,143,000.00.
- Dividend Yield: 0.00; no dividend declared (ex-dividend date null).
- Beta: 1.34 (above 1, suggests higher systemic volatility vs market).
- 52-Week High: 109.00; 52-Week Low: 33.40 โ current price near lower bound.
- Institutional Ownership: 45.41%.
- Average Volume: 790,000.00; Historical Volatility: 90.78% (very elevated).
- PEG Ratio, Forward P/E, Forward EPS, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, Total Revenue: all null in data.
- Analyst consensus and target price: not available (recommendationKey null, targetMeanPrice null).
Fundamentals show a loss-making small-cap biotech with no dividend, high volatility, and unknown margins/leverage. This diverges from the bullish options sentiment but aligns with the bearish longer-term technical backdrop (price far below 50-day SMA of 52.70).
Current Market Position
From embedded data: current price per indicators is 36.20 (as of 2026-11-05). Minute bars show 2026-11-05 open 38.36, low 35.76, close 36.20; 2026-11-06 bars show drift from 36.93 down to 36.64 by 10:40. Recent daily history shows close fall from 57.83 (2026-09-25) to 36.20 (2026-11-05).
Intraday momentum (11-06) is mildly downward: open 36.93 โ close 36.64, with lower highs/lows across last 5 minute bars. Volume on 11-05 was 411,343 vs 20-day avg 447,283 โ below average.
Technical Analysis
Technical Indicators
Price (36.20) is below SMA 5 (37.54), SMA 20 (37.92), and far below SMA 50 (52.70): bearish alignment, no bullish crossover. RSI 52.39 is neutral, not oversold. MACD (-3.93) below signal (-3.14), histogram -0.79: bearish momentum. Bollinger mid 37.92, lower 35.48 โ price near lower band, slight expansion. 30-day range 35.61โ62.40; price sits at 1.5% above 30d low.
True Sentiment Analysis (Delta 40-60 Options)
From NKTR_options_20261106 data:
Call Dollar Volume: 2470.00 (100.00%) Put Dollar Volume: 0.00 (0.00%) Total: 2470.00
Sentiment: Bullish (2 trades, 4 contracts, delta 40-60 filter). Pure directional call conviction with zero put activity. This diverges from bearish technicals (Option Spread advice: "Divergence detected between technical indicators and options sentiment"). Near-term expectations implied: modest bullish bet, but low sample (0.4% of 516 options analyzed).
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.